NCT06250647

Brief Summary

The goal of this clinical trial is to compare the effect of a high vitamin K diet intervention on vitamin K, insulin, osteocalcin serum levels and the cardiovascular risk percentage in normal weight and overweight or obese young adults. The main questions it aims to answer are: • Does a diet intervention containing 500mcg of vitamin K increases serum vitamin K levels? • Are vitamin K serum levels after the 500mcg of vitamin K diet intervention associated with insulin and osteocalcin serum levels or the cardiovascular risk percentage in normal weight and overweight or obese young adults? Participants will have to follow a diet intervention that contains 500mcg of vitamin K, given as a cyclic menu for 6 weeks. Also, participants will have to assist weekly to nutritional monitoring and to report any situation they observed regarding the intervention during this study. Researchers will compare normal weight and overweight or obese groups with diet intervention with normal weight and overweight or obese groups without diet intervention and only dietetic recommendations to see if vitamin K serum levels, insulin, osteocalcin and the cardiovascular risk percentage improve after the 6 weeks diet intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 6, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 12, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2021

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

November 27, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 9, 2024

Completed
Last Updated

February 9, 2024

Status Verified

February 1, 2024

Enrollment Period

5 months

First QC Date

November 27, 2023

Last Update Submit

February 6, 2024

Conditions

Keywords

Vitamin Kdiet interventionCardiovascular diseaseoverweight and obesityyoung adults

Outcome Measures

Primary Outcomes (3)

  • vitamin K serum levels

    ng/mL

    basal and after 6 weeks of diet intervention

  • Cardiovascular Risk Percentage

    percentage (%)

    basal and after 6 weeks of diet intervention

  • insulin serum levels

    mcUI/L

    basal and after 6 weeks of diet intervention

Secondary Outcomes (1)

  • Osteocalcin

    basal and after 6 weeks of diet intervention

Study Arms (2)

VK INTERVENTION

EXPERIMENTAL

administration of a menu diet containing 500mcg of vitamin K (in the food selected) durinf 6 weeks.

Other: vitamin K diet

DIETARY RECOMMENDATIONS

NO INTERVENTION

No menu administration but only recommendations for correct diet.

Interventions

500mcg of Vitamin K intake provided by the selection of vitamin k rich foods in the menu.

VK INTERVENTION

Eligibility Criteria

Age20 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • young adults
  • acceptation for participate
  • acceptation to asist to monitoring sessions
  • sign information consent

You may not qualify if:

  • under other dietetic intervention
  • under medications that interfere with vitamin K or diminish its absorbtion
  • vitamin E or A intake supplements
  • previous diagnose of metabolic syndrome, diabetes mellitus, hypertension, cancer or dyslipidemia.
  • chronic alcohol intake
  • some medical or health situation that impedes the following of the program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Universitario de Ciencias de la Salud

Guadalajara, Jalisco, 44340, Mexico

Location

Related Publications (7)

  • Chen HG, Sheng LT, Zhang YB, Cao AL, Lai YW, Kunutsor SK, Jiang L, Pan A. Association of vitamin K with cardiovascular events and all-cause mortality: a systematic review and meta-analysis. Eur J Nutr. 2019 Sep;58(6):2191-2205. doi: 10.1007/s00394-019-01998-3. Epub 2019 May 22.

    PMID: 31119401BACKGROUND
  • Simes DC, Viegas CSB, Araujo N, Marreiros C. Vitamin K as a Diet Supplement with Impact in Human Health: Current Evidence in Age-Related Diseases. Nutrients. 2020 Jan 3;12(1):138. doi: 10.3390/nu12010138.

    PMID: 31947821BACKGROUND
  • Vera-Remartinez EJ, Lazaro Monge R, Granero Chinesta S, Sanchez-Alcon Rodriguez D, Planelles Ramos MV. [Cardiovascular risk factors in young adults of a penitentiary center]. Rev Esp Salud Publica. 2018 Jul 6;92:e201807037. Spanish.

    PMID: 29978853BACKGROUND
  • Shea MK, Booth SL, Weiner DE, Brinkley TE, Kanaya AM, Murphy RA, Simonsick EM, Wassel CL, Vermeer C, Kritchevsky SB; Health ABC Study. Circulating Vitamin K Is Inversely Associated with Incident Cardiovascular Disease Risk among Those Treated for Hypertension in the Health, Aging, and Body Composition Study (Health ABC). J Nutr. 2017 May;147(5):888-895. doi: 10.3945/jn.117.249375. Epub 2017 Mar 29.

    PMID: 28356433BACKGROUND
  • Yoshida M, Booth SL, Meigs JB, Saltzman E, Jacques PF. Phylloquinone intake, insulin sensitivity, and glycemic status in men and women. Am J Clin Nutr. 2008 Jul;88(1):210-5. doi: 10.1093/ajcn/88.1.210.

    PMID: 18614743BACKGROUND
  • Al-Suhaimi EA, Al-Jafary MA. Endocrine roles of vitamin K-dependent- osteocalcin in the relation between bone metabolism and metabolic disorders. Rev Endocr Metab Disord. 2020 Mar;21(1):117-125. doi: 10.1007/s11154-019-09517-9.

    PMID: 31761961BACKGROUND
  • Gaona-Pineda EB, Martinez-Tapia B, Arango-Angarita A, Valenzuela-Bravo D, Gomez-Acosta LM, Shamah-Levy T, Rodriguez-Ramirez S. [Food groups consumption and sociodemographic characteristics in Mexican population]. Salud Publica Mex. 2018 May-Jun;60(3):272-282. doi: 10.21149/8803. Spanish.

MeSH Terms

Conditions

OverweightObesityCardiovascular Diseases

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Iris M Llamas-Covarrubias, PhD

    University of Guadalajara

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2023

First Posted

February 9, 2024

Study Start

February 6, 2021

Primary Completion

July 12, 2021

Study Completion

August 16, 2021

Last Updated

February 9, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
6 months after publication
Access Criteria
IPD will be shared by email request after the request review by the main researcher

Locations